Neuraminidase-triggered activation of prodrug-type substrate of 4-nitroaniline.

Clostridium perfringens Neuraminidase Prodrug Sialic acid

Journal

Bioorganic & medicinal chemistry letters
ISSN: 1464-3405
Titre abrégé: Bioorg Med Chem Lett
Pays: England
ID NLM: 9107377

Informations de publication

Date de publication:
15 01 2020
Historique:
received: 30 10 2019
revised: 27 11 2019
accepted: 01 12 2019
pubmed: 21 12 2019
medline: 17 2 2021
entrez: 21 12 2019
Statut: ppublish

Résumé

Artificial substrates for probing neuraminidase activity are powerful tools for studying the physiological and pathological roles of neuraminidases. Most of the substrates are α-O-linked sialosides involving hydroxyl-containing reporters for visualization, and neuraminidase-catalyzed cleavage of the sialic acid residues directly activates the reporters. However, the use of amine-containing reporters has been avoided because α-N-linked sialosides are marginal substrates for neuraminidases. To expand the applicability of reporters to amine-containing compounds, we have focused on prodrug design. Herein we describe the synthesis and enzymatic study of a model substrate involving 4-nitroaniline as an amine-containing chromogenic reporter. The substrate can respond to neuraminidase from Clostridium perfringens. Neuraminidase-mediated hydrolysis of the sialic acid moiety of the substrate initiates self-immolative elimination of the linker moiety, leading the liberation of yellow-colored reporter 4-nitroaniline. The elimination process involves generation of quinone methide intermediate, which causes to neutralize neuraminidase. The substrate, thus, works as not only a chromogenic substrate but also a suicide inactivator.

Identifiants

pubmed: 31859155
pii: S0960-894X(19)30861-3
doi: 10.1016/j.bmcl.2019.126883
pii:
doi:

Substances chimiques

Aniline Compounds 0
Prodrugs 0
nitroaniline 29757-24-2
Neuraminidase EC 3.2.1.18

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

126883

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Takahiko Matsushita (T)

Area for Molecular Function, Division of Material Science, Graduate School of Science and Engineering, Saitama University, Sakura, Saitama 338-8570, Japan; Medical Innovation Research Unit (MiU), Advanced Institute of Innovative Technology (AIIT), Saitama University, Sakura, Saitama 338-8570, Japan.

Monique Nami Danyel (MN)

Area for Molecular Function, Division of Material Science, Graduate School of Science and Engineering, Saitama University, Sakura, Saitama 338-8570, Japan.

Tetsuo Koyama (T)

Area for Molecular Function, Division of Material Science, Graduate School of Science and Engineering, Saitama University, Sakura, Saitama 338-8570, Japan.

Ken Hatano (K)

Area for Molecular Function, Division of Material Science, Graduate School of Science and Engineering, Saitama University, Sakura, Saitama 338-8570, Japan; Medical Innovation Research Unit (MiU), Advanced Institute of Innovative Technology (AIIT), Saitama University, Sakura, Saitama 338-8570, Japan.

Koji Matsuoka (K)

Area for Molecular Function, Division of Material Science, Graduate School of Science and Engineering, Saitama University, Sakura, Saitama 338-8570, Japan; Medical Innovation Research Unit (MiU), Advanced Institute of Innovative Technology (AIIT), Saitama University, Sakura, Saitama 338-8570, Japan. Electronic address: koji@fms.saitama-u.ac.jp.

Articles similaires

Neoplastic Stem Cells Animals Humans Aldehyde Dehydrogenase Tretinoin

Blocking Na

Baozhen Qi, Zhonglei Xie, Dongli Shen et al.
1.00
Animals NAV1.8 Voltage-Gated Sodium Channel Dogs Atrial Fibrillation Male

Dual ON/OFF-switch chimeric antigen receptor controlled by two clinically approved drugs.

Greta Maria Paola Giordano Attianese, Sailan Shui, Elisabetta Cribioli et al.
1.00
Receptors, Chimeric Antigen Humans Sulfonamides Animals T-Lymphocytes

Classifications MeSH